Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.65 USD | -2.72% | +5.92% | +78.16% |
May. 07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
May. 01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
Business Summary
Number of employees: 105
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 20-11-10 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Director of Finance/CFO | 46 | 19-11-30 | |
Howard West
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-18 |
Allen Yang
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-15 |
Will Black
CTO | Chief Tech/Sci/R&D Officer | - | - |
Dave Gancarz
PRN | Corporate Officer/Principal | - | - |
Campbell Hair
HRO | Human Resources Officer | - | 20-09-30 |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 21-11-02 |
Shelley Spray
PRN | Corporate Officer/Principal | 59 | 21-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Robert Booth
BRD | Director/Board Member | 70 | 22-09-27 |
Director of Finance/CFO | 46 | 19-11-30 | |
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 20-11-10 |
Kenneth Clark
BRD | Director/Board Member | 65 | 21-10-06 |
Director/Board Member | 63 | 22-11-14 | |
Urte Gayko
PRN | Corporate Officer/Principal | 53 | 21-11-02 |
Michelle Xia
BRD | Director/Board Member | 58 | 23-01-15 |
Ujwala Mahatme
BRD | Director/Board Member | 59 | 20-07-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 701,979,596 | 83,228,173 ( 11.86 %) | 0 | 11.86 % |
Company contact information
Sector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+78.16% | 3.26B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- SMMT Stock
- Company Summit Therapeutics Inc.